...ion channels. Investors in the C round were Forward Ventures; Boston Millennia; CMEA; Novel Bioventures; Yamanouchi Venture Capital...

...C round led by Forward Ventures; Boston Millennia; and CMEA. Other investors included Novel Bioventures; Yamanouchi Venture Capital...

...Number of employees: 6 Funds raised: E14 million ($16.5 million) Investors: Aravis; Novartis Venture Fund; Yamanouchi Venture Capital...

...MVM Ltd.; ABN AMRO; 3i; Green Highlander Cellzome Germany $32.1 Invesco; BioFrontier; SG Asset Management; Yamanouchi Venture Capital...

...targets and lead pairs. Other investors in the round included Biofrontier Partners; SG Asset Management; Yamanouchi Venture Capital...

...C round led by Invesco Private Capital. Other investors included Biofrontier Partners; SG Asset Management; Yamanouchi Venture Capital...

...D financing was led by International BM Biomedicine Holdings' Biomedicine L.P. affiliate. Other investors included Yamanouchi Venture Capital...

...Neuro money Company Businesses Raised (M) Deal date Investors Memory Pharma Neurological $40.0 25-Mar-02 Biomedicine; Yamanouchi Venture Capital...

...series D financing led by International BM Biomedicine Holdings' Biomedicine L.P. affiliate. Other investors included Yamanouchi Venture Capital...

...Meanwhile, Japanese pharma company Yamanouchi has set up a U.S. VC unit in Palo Alto. Yamanouchi Venture Capital...